Skip to main content
. 2020 Feb 18;21:199. doi: 10.1186/s13063-020-4118-5

Table 4.

Safety outcomes during hospital admission

ITT
TXA group (n = xx) Standard care group (n = xx) OR (95% CI)
Any SAE, n (%) NN (X) NN (X) X.XX (X.XX–X.XX)
Recurrent bleeding NN (X) NN (X) X.XX (X.XX–X.XX)
Hydrocephalus NN (X) NN (X) X.XX (X.XX–X.XX)
Delayed cerebral ischemia NN (X) NN (X) X.XX (X.XX–X.XX)

Thromboembolic complications during treatment

Coiling, n (%)

NN (X) NN (X) X.XX (X.XX–X.XX)

Infarct related to procedure

Clipping, n (%)

NN (X) NN (X) X.XX (X.XX–X.XX)

Procedural rupture

Coiling, n (%)

Clipping, n (%)

NN (X) NN (X) X.XX (X.XX–X.XX)
Extracranial thrombosis NN (X) NN (X) X.XX (X.XX–X.XX)
 - DVT NN (X) NN (X) X.XX (X.XX–X.XX)
 - PE NN (X) NN (X) X.XX (X.XX–X.XX)
Hemorrhagic complication NN (X) NN (X) X.XX (X.XX–X.XX)
Severe hyponatremia NN (X) NN (X) X.XX (X.XX–X.XX)
Pneumonia NN (X) NN (X) X.XX (X.XX–X.XX)
Meningitis NN (X) NN (X) X.XX (X.XX–X.XX)
Urinary tract infection NN (X) NN (X) X.XX (X.XX–X.XX)
Epilepsy NN (X) NN (X) X.XX (X.XX–X.XX)
Delirium NN (X) NN (X) X.XX (X.XX–X.XX)
Terson’s syndrome NN (X) NN (X) X.XX (X.XX–X.XX)
SUSARs NN (X) NN (X) X.XX (X.XX–X.XX)
Other NN (X) NN (X) X.XX (X.XX–X.XX)

CI confidence interval, DVT deep venous thrombosis, ITT intention to treat, OR odds ratio, PE pulmonary embolism, SAE serious adverse event, SUSARs suspected unexpected serious adverse reactions, TXA tranexamic acid